Effectiveness of an Integrated Care Pathway for Depression: Cluster Randomized Controlled Trial
Recruiting now · Not applicable
Conditions studied: Major Depressive Disorder
In brief
This a stepped wedged cluster RCT with two intervention arms--Treatment As Usual (TAU) and an Integrated Care Pathway (ICP). Eligible participants are between the ages of 13 and 18, who present to community mental health agencies with depressive symptoms as the primary concern. The primary objective is to establish the clinical effectiveness of the ICP intervention in the community setting relative to TAU, with respect to reducing evaluator-rated depressive symptoms. The secondary objectives are to explore changes in clinician-rated function and caregiver-rated symptoms for youth receiving the ICP intervention relative to TAU. The third objective is to explore the implementation effectiveness of the ICP intervention, namely investigating: feasibility, fidelity, cost and acceptability. Edited on March 7th, 2024: This is a quasi-experimental, multi-site cluster controlled clinical trial design with two intervention arms--Treatment As Usual (TAU) and an Integrated Care Pathway (ICP). Eligible participants are between the ages of 13 and 18, who present to community mental health agencies with depressive symptoms as the primary concern. The primary objective is to establish the clinical effectiveness of the ICP intervention in the community setting relative to TAU, with respect to reducing evaluator-rated depressive symptoms. The secondary objectives are to explore changes in clinician-rated function and caregiver-rated symptoms for youth receiving the ICP intervention relative to TAU. The third objective is to explore the implementation effectiveness of the ICP intervention in the community setting, namely investigating: feasibility, fidelity, cost and acceptability.
Key facts
- Study ID
- NCT05142683
- Run by
- Centre for Addiction and Mental Health
- People needed
- 300
- Starts
- 2022-02-01
- Expected to finish
- 2027-09-30
- Last updated by the study team
- 2024-03-22
Who can join
Age: 13 and older, up to 18. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Youth is aged 13 to 18 years, inclusive.
- Youth and/or their caregiver is expressing that 'depression" (or some synonym) is a concern.
- Clinician agrees that depressive symptoms are a treatment target.
- Mood and Feelings Questionnaire score is ≥22 at two sequential visits (screening and baseline assessment).
- Youth must be new to the site (in past 3 months) or have a period of no treatment for 3 months
You may not qualify if…
- Known or highly suspected presentations of psychotic symptoms that are persistent, affect functioning, and have observable effects on behaviour.
- Severe substance use disorder, bipolar disorder, autism spectrum disorder or intellectual disability, severe eating disorder, imminent risk of suicide requiring hospitalization as per judgment of the assessing clinician.
- Inability to provide informed consent to the study for any reason
- Youth currently in Day Treatment
Where it is running
- Centre for Addiction and Mental Health — Toronto, Ontario, Canada (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.